| Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis W Van Rheenen, A Shatunov, AM Dekker, RL McLaughlin, FP Diekstra, ... Nature genetics 48 (9), 1043-1048, 2016 | 588 | 2016 |
| Genome-wide analyses identify KIF5A as a novel ALS gene A Nicolas, KP Kenna, AE Renton, N Ticozzi, F Faghri, R Chia, ... Neuron 97 (6), 1268-1283. e6, 2018 | 576 | 2018 |
| Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA polymerase-γA G Ferrari, E Lamantea, A Donati, M Filosto, E Briem, F Carrara, R Parini, ... Brain 128 (4), 723-731, 2005 | 335 | 2005 |
| Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology W Van Rheenen, RAA Van Der Spek, MK Bakker, JJFA Van Vugt, PJ Hop, ... Nature genetics 53 (12), 1636-1648, 2021 | 275 | 2021 |
| Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy A Benussi, A Pilotto, E Premi, I Libri, M Giunta, C Agosti, A Alberici, ... Neurology 95 (7), e910-e920, 2020 | 261 | 2020 |
| Guillain-Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions M Filosto, SC Piccinelli, S Gazzina, C Foresti, B Frigeni, MC Servalli, ... Journal of Neurology, Neurosurgery & Psychiatry 92 (7), 751-756, 2021 | 216 | 2021 |
| Phenotypic heterogeneity of the 8344A> G mtDNA “MERRF” mutation M Mancuso, D Orsucci, C Angelini, E Bertini, V Carelli, GP Comi, C Minetti, ... Neurology 80 (22), 2049-2054, 2013 | 204 | 2013 |
| The role of mitochondria in neurodegenerative diseases M Filosto, M Scarpelli, MS Cotelli, V Vielmi, A Todeschini, V Gregorelli, ... Journal of neurology 258, 1763-1774, 2011 | 161 | 2011 |
| Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years C Angelini, C Semplicini, S Ravaglia, B Bembi, S Servidei, E Pegoraro, ... Journal of neurology 259, 952-958, 2012 | 156 | 2012 |
| The m. 3243A> G mitochondrial DNA mutation and related phenotypes. A matter of gender? M Mancuso, D Orsucci, C Angelini, E Bertini, V Carelli, GP Comi, A Donati, ... Journal of neurology 261, 504-510, 2014 | 155 | 2014 |
| Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy JP Halter, W Michael, M Schüpbach, H Mandel, C Casali, K Orchard, ... Brain 138 (10), 2847-2858, 2015 | 153 | 2015 |
| Mutations in DNA2 link progressive myopathy to mitochondrial DNA instability D Ronchi, A Di Fonzo, W Lin, A Bordoni, C Liu, E Fassone, S Pagliarani, ... The American Journal of Human Genetics 92 (2), 293-300, 2013 | 148 | 2013 |
| Atypical CIDP: diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database PE Doneddu, D Cocito, F Manganelli, R Fazio, C Briani, M Filosto, ... Journal of Neurology, Neurosurgery & Psychiatry 90 (2), 125-132, 2019 | 144 | 2019 |
| Neuropathology of mitochondrial diseases M Filosto, G Tomelleri, P Tonin, M Scarpelli, G Vattemi, N Rizzuto, ... Bioscience reports 27, 23-30, 2007 | 144 | 2007 |
| A genome-wide association meta-analysis identifies a novel locus at 17q11. 2 associated with sporadic amyotrophic lateral sclerosis I Fogh, A Ratti, C Gellera, K Lin, C Tiloca, V Moskvina, L Corrado, ... Human molecular genetics 23 (8), 2220-2231, 2014 | 138 | 2014 |
| Clinical and genetic heterogeneity in progressive external ophthalmoplegia due to mutations in polymerase γ M Filosto, M Mancuso, Y Nishigaki, J Pancrudo, Y Harati, C Gooch, ... Archives of neurology 60 (9), 1279-1284, 2003 | 137 | 2003 |
| Genetic correlation between amyotrophic lateral sclerosis and schizophrenia RL McLaughlin, D Schijven, W Van Rheenen, KR Van Eijk, M O’brien, ... Nature communications 8 (1), 14774, 2017 | 135 | 2017 |
| Physical activity and amyotrophic lateral sclerosis: A European population‐based case–control study E Pupillo, P Messina, G Giussani, G Logroscino, S Zoccolella, A Chiò, ... Annals of neurology 75 (5), 708-716, 2014 | 132 | 2014 |
| Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial MG Hanna, UA Badrising, O Benveniste, TE Lloyd, M Needham, H Chinoy, ... The Lancet Neurology 18 (9), 834-844, 2019 | 117 | 2019 |
| Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3 L Maggi, L Bello, S Bonanno, A Govoni, C Caponnetto, L Passamano, ... Journal of Neurology, Neurosurgery & Psychiatry 91 (11), 1166-1174, 2020 | 116 | 2020 |
